NZ517348A - Use of a mycobacterial extract in the treatment of inflammatory bowel disease - Google Patents

Use of a mycobacterial extract in the treatment of inflammatory bowel disease

Info

Publication number
NZ517348A
NZ517348A NZ517348A NZ51734802A NZ517348A NZ 517348 A NZ517348 A NZ 517348A NZ 517348 A NZ517348 A NZ 517348A NZ 51734802 A NZ51734802 A NZ 51734802A NZ 517348 A NZ517348 A NZ 517348A
Authority
NZ
New Zealand
Prior art keywords
treatment
inflammatory bowel
bowel disease
mycobacterial extract
mycobacterial
Prior art date
Application number
NZ517348A
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5940A external-priority patent/AUPO594097A0/en
Priority claimed from AUPO9785A external-priority patent/AUPO978597A0/en
Application filed by Borody Thomas J filed Critical Borody Thomas J
Priority claimed from NZ500696A external-priority patent/NZ500696A/en
Publication of NZ517348A publication Critical patent/NZ517348A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Use of Regressin, a mycobacterial extract or product for the manufacture of a medicament for the treatment of inflammatory bowel disease.
NZ517348A 1997-04-01 1998-04-01 Use of a mycobacterial extract in the treatment of inflammatory bowel disease NZ517348A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5940A AUPO594097A0 (en) 1997-04-01 1997-04-01 Novel methods of treating inflammatory bowel disease
AUPO9785A AUPO978597A0 (en) 1997-10-14 1997-10-14 Methods of treating inflammatory bowel disease
NZ500696A NZ500696A (en) 1997-04-01 1998-04-01 Methods and compositions for treating inflammatory bowel disease comprising mycobacterial agents, including macrolides

Publications (1)

Publication Number Publication Date
NZ517348A true NZ517348A (en) 2002-09-27

Family

ID=27157984

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ517348A NZ517348A (en) 1997-04-01 1998-04-01 Use of a mycobacterial extract in the treatment of inflammatory bowel disease

Country Status (1)

Country Link
NZ (1) NZ517348A (en)

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
ZA9811029B (en) Tampon for feminine hygiene or medical purposes, and process for producing the same.
DE69905368D1 (en) Oxydiertes thymosin beta 4
HK1028594A1 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
NL300258I2 (en) Pharmaceutical composition for use in the treatment of.
FI956014A (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
MXPA03002070A (en) Contraception process and administration form for the same.
MY125978A (en) Admantane derivatives
SE9704546D0 (en) Novel compounds
HK1009814A1 (en) Five-membered heterocycles having biphenylsulfonylsubstitution, process for their prparation, their use as a medicament or diagnostic, and medicament .
EP0630630A3 (en) Disposable undergarment.
HUP0301333A2 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
EP0630632A3 (en) Disposable undergarment.
HK1040980A1 (en) Biphenylsulfonylcyanamides,process for their preparation, and their use as medicament
BG101401A (en) Cisaspide extended release oral compositions
EP0630631A3 (en) Disposable undergarment.
MXPA01003761A (en) Remedies for ocular diseases.
GB0021776D0 (en) The treatment of inflammatory disorders
ZA989571B (en) 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use.
NZ517348A (en) Use of a mycobacterial extract in the treatment of inflammatory bowel disease
WO2000063348A3 (en) Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
ZA991783B (en) Therapeutic treatment for autoimmune diseases.

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: ADVERTISED IN ERROR IN JOURNAL 1479

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired